Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human minibody against complement component C5

EU orphan designation number: EU/3/08/571   
Active ingredient: Recombinant human minibody against complement component C5
Indication: Treatment of atypical Haemolytic Uraemic Syndrome (aHUS) associated with an inherited abnormality of the complement system
Sponsor: ADIENNE S.r.l.
Via Galileo Galilei 19, 20867 Caponago (MB), Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/09/2008 Centralised Orphan - Designation EMEA/OD/035/08 (2008)5454 of 22/09/2008
15/01/2014 Centralised Orphan - Change of address